<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8804207</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1862</journal-id>
<journal-id journal-id-type="nlm-ta">Schizophr Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Schizophr. Res.</journal-id>
<journal-title-group>
<journal-title>Schizophrenia research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0920-9964</issn>
<issn pub-type="epub">1573-2509</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30442475</article-id>
<article-id pub-id-type="pmc">6591017</article-id>
<article-id pub-id-type="doi">10.1016/j.schres.2018.10.021</article-id>
<article-id pub-id-type="manuscript">NIHMS1019677</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Critical period plasticity-related transcriptional aberrations in schizophrenia and bipolar disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Milo R.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Readhead</surname>
<given-names>Ben</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dudley</surname>
<given-names>Joel T.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="corresp" rid="CR2">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morishita</surname>
<given-names>Hirofumi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="aff" rid="A8">h</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A2"><label>b</label>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A3"><label>c</label>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A4"><label>d</label>Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A5"><label>e</label>Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A6"><label>f</label>Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A7"><label>g</label>Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<aff id="A8"><label>h</label>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY 10029, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Contributions</p>
<p id="P2">M.R.S. and H.M. designed study, M.R.S. and B.R. performed analyses, M.R.S., B.R., J.T.D., and H.M. contributed to and approved the final manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence to: H. Morishita, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA.</corresp>
<corresp id="CR2"><label>**</label>Correspondence to: J. T. Dudley, One Gustave L. Levy Place, New York, NY 10029, USA., <email>milo.smith@icahn.mssm.edu</email> (M.R. Smith), <email>ben.readhead@mssm.edu</email> (B. Readhead), <email>joel.dudley@mssm.edu</email> (J.T. Dudley), <email>hirofumi.morishita@mssm.edu</email> (H. Morishita).</corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P37">Conflict of interest</p>
<p id="P38">Authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>207</volume>
<fpage>12</fpage>
<lpage>21</lpage>
<!--elocation-id from pubmed: 10.1016/j.schres.2018.10.021-->
<abstract id="ABS1">
<p id="P3">Childhood critical periods of experience-dependent plasticity are essential for the development of environmentally appropriate behavior and cognition. Disruption of critical periods can alter development of normal function and confer risk for neurodevelopmental disorders. While genes and their expression relevant to neurodevelopment are associated with schizophrenia, the molecular relationship between schizophrenia and critical periods has not been assessed systematically. Here, we apply a transcriptome-based bioinformatics approach to assess whether genes associated with the human critical period for visual cortex plasticity, a well-studied model of cortical critical periods, are aberrantly expressed in schizophrenia and bipolar disorder. Across two dozen datasets encompassing 522 cases and 374 controls, we find that the majority show aberrations in expression of genes associated with the critical period. We observed both hyper-and hypo-critical period plasticity phenotypes at the transcriptome level, which partially mapped to drug candidates that reverse the disorder signatures in silico. Our findings indicate plasticity aberrations in schizophrenia and their treatment may need to be considered in the context of subpopulations with elevated and others reduced plasticity. Future work should leverage ongoing consortia RNA-sequencing efforts to tease out the sources of plasticity-related transcriptional aberrations seen in schizophrenia, including true biological heterogeneity, interaction between normal development/aging and the disorder, and medication history. Our study also urges innovation towards direct assessment of visual cortex plasticity in humans with schizophrenia to precisely deconstruct the role of plasticity in this disorder.</p>
</abstract>
<kwd-group>
<kwd>Neuroplasticity</kwd>
<kwd>Critical period</kwd>
<kwd>Transcriptome</kwd>
<kwd>Drug repurposing</kwd>
<kwd>Bioinformatics</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>